Dissolving may be considered for an urgent vascular complication, infection-related management, persistent lumps, migration, overcorrection or an aesthetic result a client no longer wants. These are not all treated in the same way.
Emergency and elective dissolving are different
Suspected vascular occlusion is time-critical and needs immediate assessment and a complication protocol. Elective correction should be calm and planned; swelling, anatomy and the possibility of staged treatment need to be considered.
Different fillers dissolve differently
Laboratory studies show meaningful differences in susceptibility to hyaluronidase between HA gels. More cross-linked or structurally resistant products may require different doses, dilution, distribution and repeat assessment. In-vitro rankings do not perfectly predict what happens in living tissue.
Hyaluronidase has its own risks
Temporary swelling, bruising, discomfort and loss of desired correction can occur. Allergic reactions are uncommon but possible. The enzyme may affect naturally occurring HA temporarily, while the body continues to make HA.
Assessment before reinjection
It is often sensible to allow inflammation to settle and reassess the untreated anatomy before adding more filler. Rebuilding immediately can hide the original problem and encourage a cycle of correction.
The bottom line
A reversible product is not a risk-free product. Good filler practice includes knowing how to recognise complications, when to dissolve and when to refer.Sources & further reading
PubMed: time- and dose-dependent filler degradation ↗PubMed: comparative degradability study ↗Editorial note: information checked August 2026. This article is general education, not personal medical advice. Suitability and risk must be assessed individually.